| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 7 |
| 1 | PANCRELIPASE | 7 |
| 2 | PEMBROLIZUMAB | 5 |
| 3 | PREDNISONE | 5 |
| 4 | AMBRISENTAN | 3 |
| 5 | ASPIRIN | 3 |
| 6 | ASPIRIN 325 MG | 3 |
| 7 | ASPIRIN 81 MG | 3 |
| 8 | CAPECITABINE | 3 |
| 9 | CARBOPLATIN | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DOCUSATE SODIUM 50 MG SENNOSIDES 8.6 MG | 1 | 0.0013 |
| 1 | SENNOSIDES 8.6MG AND DOCUSATE SODIUM 50MG | 1 | 0.0013 |
| 2 | DOCUSATE SODIUM 50MG AND SENNOSIDES 8.6MG | 1 | 0.0011 |
| 3 | CIDOFOVIR ANHYDROUS | 1 | 0.0007 |
| 4 | RIPRETINIB | 2 | 0.0004 |
| 5 | SENNOSIDES AND DOCUSATE SODIUM | 1 | 0.0003 |
| 6 | FINERENONE | 1 | 0.0003 |
| 7 | ENASIDENIB MESYLATE | 1 | 0.0003 |
| 8 | INSULIN GLARGINE AND LIXISENATIDE | 1 | 0.0003 |
| 9 | FOSINOPRIL | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Somatostatin Analog [EPC] | 1 | 0.0001 |
| 1 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |
| 2 | Antifibrinolytic Agent [EPC] | 1 | 0.0001 |
| 3 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |
| 4 | Antimetabolite Immunosuppressant [EPC] | 2 | 0.0001 |
| 5 | GLP-2 Analog [EPC] | 1 | 0.0001 |
| 6 | Anticholinergic [EPC] | 1 | 0.0001 |
| 7 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 6 | 0.0001 |
| 8 | Rifamycin Antibacterial [EPC] | 2 | 0.0001 |
| 9 | Cholinesterase Inhibitor [EPC] | 1 | 0.0001 |